Cumberland Pharmaceuticals Inc. (CPIX)
Largest Insider Buys in Sector
CPIX Stock Price History Chart
CPIX Stock Performance
About Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the …
Insider Activity of Cumberland Pharmaceuticals Inc.
Over the last 12 months, insiders at Cumberland Pharmaceuticals Inc. have bought $27,287 and sold $0 worth of Cumberland Pharmaceuticals Inc. stock.
On average, over the past 5 years, insiders at Cumberland Pharmaceuticals Inc. have bought $79,399 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Krogulski Kenneth (director) — $18,454. Jones James (director) — $3,582. KAZIMI A J (Chairman and CEO) — $3,582.
The last purchase of 75 shares for transaction amount of $99 was made by KAZIMI A J (Chairman and CEO) on 2024‑11‑29.
List of Insider Buy and Sell Transactions, Cumberland Pharmaceuticals Inc.
| 2024-11-29 | Chairman and CEO | 75 0.0005% | $1.32 | $99 | +51.43% | |||
| 2024-11-29 | director | 474 0.0032% | $1.32 | $626 | +51.43% | |||
| 2024-11-29 | director | 75 0.0005% | $1.32 | $99 | +51.43% | |||
| 2024-11-29 | director | 16 0.0001% | $1.32 | $21 | +51.43% | |||
| 2024-11-27 | Chairman and CEO | 75 0.0005% | $1.15 | $86 | +54.74% | |||
| 2024-11-27 | director | 474 0.003% | $1.15 | $545 | +54.74% | |||
| 2024-11-27 | director | 75 0.0005% | $1.15 | $86 | +54.74% | |||
| 2024-11-27 | director | 16 <0.0001% | $1.15 | $18 | +54.74% | |||
| 2024-11-26 | Chairman and CEO | 75 0.0005% | $1.11 | $83 | +58.56% | |||
| 2024-11-26 | director | 474 0.0033% | $1.11 | $526 | +58.56% | |||
| 2024-11-26 | director | 75 0.0005% | $1.11 | $83 | +58.56% | |||
| 2024-11-26 | director | 16 0.0001% | $1.09 | $17 | +58.56% | |||
| 2024-11-25 | Chairman and CEO | 75 0.0005% | $1.09 | $82 | +32.08% | |||
| 2024-11-25 | director | 474 0.0035% | $1.09 | $517 | +32.08% | |||
| 2024-11-25 | director | 75 0.0005% | $1.09 | $82 | +32.08% | |||
| 2024-11-25 | director | 16 0.0001% | $1.09 | $17 | +32.08% | |||
| 2024-11-22 | Chairman and CEO | 75 0.0005% | $1.07 | $80 | +30.66% | |||
| 2024-11-22 | director | 474 0.0034% | $1.07 | $507 | +30.66% | |||
| 2024-11-22 | director | 75 0.0005% | $1.07 | $80 | +30.66% | |||
| 2024-11-22 | director | 16 0.0001% | $1.07 | $17 | +30.66% |
Insider Historical Profitability
| KAZIMI A J | Chairman and CEO | 5701527 40.6025% | $2.51 | 330 | 1 | <0.0001% |
| Krogulski Kenneth | director | 271627 1.9343% | $2.51 | 346 | 0 | <0.0001% |
| Jones James | director | 39377 0.2804% | $2.51 | 225 | 0 | <0.0001% |
| Young Caroline | director | 29664 0.2112% | $2.51 | 336 | 0 | <0.0001% |
| Edwards Robert | director | 400970 2.8554% | $2.51 | 1 | 1 | <0.0001% |
Institutional Investor Ownership
| Renaissance Technologies | $912,000.00 | 3.82 | 542,663 | -1.31% | -$12,100.33 | <0.01 | |
| The Vanguard Group | $628,742.00 | 2.64 | 374,251 | 0% | +$0 | <0.0001 | |
| Dimensional Fund Advisors | $600,793.00 | 2.52 | 357,615 | -2.27% | -$13,975.92 | <0.0001 | |
| Bridgeway Capital Management | $481,580.00 | 2.02 | 286,655 | 0% | +$0 | 0.01 | |
| Acadian Asset Management | $315,000.00 | 1.33 | 188,164 | 0% | +$0 | <0.01 |